Market Size of China Pharmaceutical Packaging Industry
Study Period | 2019 - 2029 |
Base Year For Estimation | 2023 |
Market Size (2024) | USD 19.52 Billion |
Market Size (2029) | USD 27.10 Billion |
CAGR (2024 - 2029) | 6.78 % |
Market Concentration | Low |
Major Players*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
China Pharmaceutical Packaging Market Analysis
The China Pharmaceutical Packaging Market size is estimated at USD 19.52 billion in 2024, and is expected to reach USD 27.10 billion by 2029, growing at a CAGR of 6.78% during the forecast period (2024-2029).
The growth of the Chinese pharmaceutical sector creates business opportunities for the country's pharmaceutical packaging companies. China's pharmaceutical packaging firms are encouraged to develop research and development teams to explore innovative, environmentally friendly, safe, functional, and sustainable packaging materials and products.
- The Chinese government's policies to advance the transformation of the country's medicine industry are expected to promote the development of the pharmaceutical packaging sector. China is actively upgrading its pharmaceutical packaging facilities and materials and diversifying its pharmaceutical products, bringing new opportunities to pharmaceutical packaging firms.
- The Chinese pharmaceutical industry operates within a framework of stringent regulatory standards enforced by authorities such as the China Food and Drug Administration (CFDA) and the National Medical Products Administration (NMPA). These standards encompass various aspects of packaging design, material composition, labeling requirements, and safety protocols. Compliance with these standards is non-negotiable and requires meticulous attention to detail in packaging practices.
- Nanotechnology enables the development of nanostructured materials that can enhance the stability of drugs by protecting them from environmental factors such as light, moisture, and oxygen. This leads to increased shelf-life and efficacy of pharmaceutical products. Nanotechnology enables the development of smart packaging solutions that can monitor the condition of the drug and provide real-time feedback on factors such as temperature, humidity, and exposure to light. This helps ensure the quality and efficacy of pharmaceutical products throughout their lifecycle.
- In the pharmaceutical packaging market, raw materials such as bottles, vials, blister packs, and labels are essential for manufacturing packaging materials. Suppliers of raw materials wield significant bargaining power, especially when they hold a dominant position in the market or when the raw material is scarce. They can leverage this power to increase prices or impose unfavorable terms on pharmaceutical packaging manufacturers. This, in turn, can lead to higher production costs for packaging materials.
- Plastic packaging has emerged as a formidable player in the packaging industry due to its advantageous properties, such as lightweight, high durability, versatility, and cost-effectiveness. It has widespread application in various industries, including medicine, healthcare, and other sectors requiring packaging support. The development of material packaging in China has a rich history and has matured into a well-established industrial chain. In this chain, the upstream sector comprises raw material suppliers responsible for providing synthetic resins and plastic additives for manufacturing plastic packaging materials.
China Pharmaceutical Packaging Industry Segmentation
The study considers revenues accrued from the sales of different pharmaceutical packaging products offered by various vendors operating in the market. The market is tracked in terms of revenue in USD. This report analyzes the factors that impact geopolitical developments in the studied market based on the prevalent base scenarios, key themes, and application of vertical-related demand cycles. The estimates for the Chinese pharmaceutical packaging market include all the costs associated with pharmaceutical packaging solution manufacturing, from raw material procurement to the end-user industry. It includes the cost of material used, the cost of other associated products such as inks and adhesives, closures, and the cost of related services like finishing, printing, labeling and marking, packing, and transporting. The estimates exclude the cost of the content that is or is to be packed inside the pharmaceutical packaging solution.
The Chinese pharmaceutical packaging market is segmented by packaging type (primary packaging (pharmaceutical plastic bottles, bottles and jars, blister packaging, pre-fillable syringes, vials and ampoules, IV containers, prefillable inhalers, and other primary packaging products) and secondary packaging (folding boxes and cartons (paper-based), corrugated shipping containers (paper-based), bags and pouches (flexible), clamshells (paper and plastic), and other secondary packaging products)). The report offers market forecasts and size in value (USD) for all the above segments.
By Primary Packaging | |
Pharmaceutical Plastic Bottles | |
Bottles and Jars | |
Blister Packaging | |
Pre-fillable Syringes | |
Vials and Ampoules | |
IV Containers | |
Prefillable Inhalers | |
Other Primary Packaging Products (Pouches, Tubes, Caps, Closures, Etc.) |
By Secondary Packaging | |
Folding Boxes and Cartons (Paper-based) | |
Corrugated Shipping Containers (Paper-based) | |
Bags and Pouches (Flexible) | |
Clamshells (Paper and Plastic) | |
Other Secondary Packaging Products (Trays, Labels among Others) |
China Pharmaceutical Packaging Market Size Summary
The Chinese pharmaceutical packaging market is poised for significant growth, driven by the expanding pharmaceutical sector and supportive government policies. Companies in this market are encouraged to invest in research and development to create innovative and sustainable packaging solutions. The market is characterized by stringent regulatory standards set by authorities like the China Food and Drug Administration and the National Medical Products Administration, which govern various aspects of packaging. These regulations ensure that packaging materials and designs meet high safety and quality standards. The integration of nanotechnology in packaging is also emerging, offering advancements such as smart packaging solutions that enhance drug stability and efficacy by monitoring environmental conditions.
The market is highly fragmented, with both global players and local enterprises competing for market share. Key players are focusing on strategic partnerships and acquisitions to strengthen their offerings. The demand for specific packaging types, such as glass vials and ampoules, is increasing due to their durability and safety features, particularly in the context of rising healthcare investments and drug spending. Additionally, the popularity of plastic packaging continues to grow, attributed to its lightweight and cost-effective properties. Innovations in packaging materials, such as the introduction of next-generation glass tubing and fully recyclable laminates, are further driving market expansion. The market's growth is also supported by the increasing prevalence of chronic diseases and the aging population, which heightens the demand for effective pharmaceutical packaging solutions.
China Pharmaceutical Packaging Market Size - Table of Contents
-
1. MARKET INSIGHTS
-
1.1 Market Overview
-
1.2 Industry Ecosystem Analysis
-
1.3 Industry Attractiveness - Porter's Five Forces Analysis
-
1.3.1 Bargaining Power of Suppliers
-
1.3.2 Bargaining Power of Buyers
-
1.3.3 Threat of New Entrants
-
1.3.4 Threat of Substitutes
-
1.3.5 Intensity of Competitive Rivalry
-
-
1.4 Industry Regulations, Policies, and Standards for Pharmaceutical Packaging
-
1.5 Recent Innovations and New Product Development in the Pharmaceutical Packaging Industry
-
1.6 Raw Material Analysis
-
-
2. MARKET SEGMENTATION
-
2.1 By Primary Packaging
-
2.1.1 Pharmaceutical Plastic Bottles
-
2.1.2 Bottles and Jars
-
2.1.3 Blister Packaging
-
2.1.4 Pre-fillable Syringes
-
2.1.5 Vials and Ampoules
-
2.1.6 IV Containers
-
2.1.7 Prefillable Inhalers
-
2.1.8 Other Primary Packaging Products (Pouches, Tubes, Caps, Closures, Etc.)
-
-
2.2 By Secondary Packaging
-
2.2.1 Folding Boxes and Cartons (Paper-based)
-
2.2.2 Corrugated Shipping Containers (Paper-based)
-
2.2.3 Bags and Pouches (Flexible)
-
2.2.4 Clamshells (Paper and Plastic)
-
2.2.5 Other Secondary Packaging Products (Trays, Labels among Others)
-
-
China Pharmaceutical Packaging Market Size FAQs
How big is the China Pharmaceutical Packaging Market?
The China Pharmaceutical Packaging Market size is expected to reach USD 19.52 billion in 2024 and grow at a CAGR of 6.78% to reach USD 27.10 billion by 2029.
What is the current China Pharmaceutical Packaging Market size?
In 2024, the China Pharmaceutical Packaging Market size is expected to reach USD 19.52 billion.